TABLE 2.
Isolate | MIC (μg/ml) for antibiotic:
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nalidixic acid | Norfloxacin | Pefloxacin | Fleroxacin | Ofloxacin | Ciprofloxacin | Levofloxacin | Sparfloxacin | Grepafloxacin | Gatifloxacin | Trovafloxacin | Moxifloxacin | Clinafloxacin | Sitafloxacin | Gemifloxacin | Ceftriaxone | |
B. burgdorferi sensu stricto | ||||||||||||||||
B31 | 256 | 8 | 16 | >16 | 4 | 1 | 2 | 0.50 | 0.25 | 0.50 | 0.50 | 1 | 0.50 | 0.25 | 0.06 | 0.03 |
LW2 | 256 | 8 | 16 | >16 | 8 | 2 | 4 | 1 | 1 | 2 | 0.12 | 2 | 1 | 0.50 | 0.12 | 0.03 |
PKa-I | 256 | 8 | 16 | 16 | 8 | 1 | 2 | 1 | 0.25 | 0.50 | 0.50 | 1 | 0.50 | 0.25 | 0.12 | 0.015 |
B. garinii | ||||||||||||||||
PTrob | 256 | 4 | 32 | >16 | 8 | 1 | 4 | 4 | 0.25 | 0.50 | 0.50 | 1 | 0.50 | 0.50 | 0.06 | 0.03 |
G1 | 256 | 4 | 16 | >16 | 4 | 1 | 2 | 0.25 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.25 | 0.06 | <0.015 |
PSth | 256 | 2 | 8 | 8 | 2 | 0.50 | 1 | 0.50 | 0.12 | 0.25 | 0.50 | 0.50 | 0.50 | 0.12 | 0.06 | 0.015 |
B. afzelii | ||||||||||||||||
EB1 | 256 | 4 | 16 | >16 | 4 | 1 | 2 | 0.50 | 0.50 | 0.50 | 1 | 1 | 1 | 0.25 | 0.12 | 0.03 |
FEM1 | 128 | 2 | 8 | 8 | 2 | 0.50 | 1 | 0.50 | 0.25 | 0.25 | 0.25 | 1 | 0.25 | 0.50 | 0.06 | 0.03 |
PKo | 128 | 2 | 4 | 16 | 2 | 0.50 | 2 | 0.25 | 0.25 | 0.50 | 0.50 | 0.50 | 0.50 | 0.25 | 0.06 | 0.03 |
B. valaisiana VS116 | 512 | 8 | 32 | >16 | 8 | 2 | 4 | 0.50 | 0.50 | 1 | 0.50 | 2 | 1 | 0.25 | 0.12 | 0.03 |
B. bissettii 25015 | 256 | 8 | 32 | 16 | 8 | 1 | 2 | 0.50 | 0.25 | 0.50 | 1 | 1 | 0.50 | 0.50 | 0.06 | 0.03 |
Antimicrobial susceptibilities were determined on three different days, and MICs for each isolate were reported as the median of three experiments.